Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01619410 · ClinicalTrials.gov registry record · NA
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01619410 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 25 participants.
The verdict
NCT01619410, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
In this pilot study, the objective is to determine the prevalence of asymptomatic carriage of S. aureus in patients with ABSSSIs and minor cutaneous abscesses after therapy with either linezolid or clindamycin at 40 days after the completion of therapy. Secondarily, the investigators will assess the efficacy of linezolid vs. clindamycin in the empiric therapy of ABSSSIs and minor cutaneous abscesses, as well as the genotypic spectrum of S. aureus isolates causing ABSSSIs or minor cutaneous abscesses and colonization in the target patient population before and after therapy. Given the results of a recent study on linezolid and vancomycin and the investigator's own experience, it is hypothesized that persistent MRSA carriage will be less common after therapy with linezolid for ABSSSIs and minor cutaneous abscesses than it is with oral clindamycin.
Interventions
- BIOLOGICAL Linezolid
- BIOLOGICAL Clindamycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01619410
The ClinicalTrials.gov registry entry for NCT01619410 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Linezolid is the first listed.
NCT01619410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01619410 about?
NCT01619410 is a clinical study titled "Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections". In this pilot study, the objective is to determine the prevalence of asymptomatic carriage of S. aureus in patients with ABSSSIs and minor cutaneous abscesses after therapy with either linezolid or clindamycin at 40 days after the completion of therapy. Secondarily, the investigators will assess the...
What is the current status of trial NCT01619410?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2012-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01619410?
The interventions under investigation include: Linezolid (BIOLOGICAL), Clindamycin (BIOLOGICAL).
Who is sponsoring clinical trial NCT01619410?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.